[Cost analysis of Shenqi Fuzheng injection on reducing adverse effects during chemotherapy].

Zhonghua Liu Xing Bing Xue Za Zhi

Department of Pulmonary Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Published: February 2003

Objective: The goals of this work was to analyse the cost of Shenqi Fuzheng injection-an extraction of a Chinese traditional herbs on reducing adverse effects in lung cancer patients during chemotherapy.

Methods: In a randomized cross-over trial, each patient completed two identical cisplatin-based chemotherapy cycles, one with Shenqi Fuzheng injection, another without Shenqi Fuzheng injection. Adverse effects and change scores of quality of life (QOL) during chemotherapy were compared in tow cycles. The direct cost dealing with adverse effect and cost-effectiveness analysis were taken.

Results: One hundred and thirty were enrolled with 123 of whom were evaluable. The patient characteristics were well balanced between the two groups. The chemotherapy cycles with Shenqi Fuzheng injection spent 220.5 more Chinese yuan, but the adverse effect of leukopenia, thrombocytopenia and vomiting were slight different and the change of score of several QOL domains showed significant better as compared to those in another cycle.

Conclusion: Shenqi Fuzheng injection could reduce the severity of toxicity related to chemotherapy and improve the QOL of patients and had some benefits in terms of cost-effectiveness.

Download full-text PDF

Source

Publication Analysis

Top Keywords

shenqi fuzheng
24
fuzheng injection
20
adverse effects
12
reducing adverse
8
chemotherapy cycles
8
cycles shenqi
8
shenqi
6
fuzheng
6
injection
5
adverse
5

Similar Publications

Bayesian network Meta-analysis was conducted to assess the efficacy and safety of different Chinese medicine injections for dilated cardiomyopathy(DCM). CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, EMbase, Cochrane Library, ProQuest, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov were searched for the randomized controlled trial(RCT) from the inception to January 2024.

View Article and Find Full Text PDF

Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model.

Breast Cancer (Dove Med Press)

August 2024

Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.

Background: Shenqi Fuzheng Injection (SQFZ) is a traditional Chinese medicine injection consists of extracts of and . Combining SQFZ with conventional chemotherapy may improve the therapeutic efficacy and reduce side-effects of chemotherapy. However, the mechanisms of SQFZ reducing cisplatin-induced kidney injury are still unclear.

View Article and Find Full Text PDF

A magnetic biochar nanomaterial derived from fungal hyphae was introduced into the sample preparation field. The magnetic fungal hyphae-derived biomass carbon (MFHBC) could be produced by a controllable hydrothermal method. In order to obtain the best sorbent for magnetic solid-phase extraction (MSPE), the reaction conditions containing temperature, time and the consumption of fungal hyphae were investigated.

View Article and Find Full Text PDF

Cancer-related fatigue (CRF) significantly impacts the quality of life of cancer patients. This study investigates the therapeutic potential of Shenqi Fuzheng injection (SFI) in managing CRF, focusing on its mechanistic action in skeletal muscle. We utilized a CRF mouse model to examine the effects of SFI on physical endurance, monitoring activity levels, swimming times and rest periods.

View Article and Find Full Text PDF

Shenqi Fuzheng injection hinders non-small cell lung cancer cell growth by regulating the Bax/Bcl-2 signaling pathway.

Discov Oncol

May 2024

No. 2 Department of Thoracic Surgery, Beijing Chest Hospital/Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.

Article Synopsis
  • Lung cancer (LC) is a leading cause of cancer deaths globally, and combining SFI with chemotherapy shows potential for improving patient outcomes and reducing side effects in non-small cell lung cancer (NSCLC) patients.
  • A meta-analysis using advanced techniques (like UPLC-MS) and various assays demonstrated that SFI enhances chemotherapy effectiveness, inhibits cancer cell growth and migration, and promotes apoptosis in NSCLC cells.
  • SFI's active components, primarily flavonoids and terpenoids, may work by increasing the expression of pro-apoptotic proteins while decreasing anti-apoptotic proteins, effectively slowing tumor growth in mouse models.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!